Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Table 10

The relationship between mGPS and PS and 3-month survival rate (%, SE) in patients with TNM stage IIIb/IV NSCLC and receiving palliative chemotherapy (𝑛=138).

PS	mGPS			Total number of patients
	0	1	2
0	NC	NC	NC	13
1	92% (7)	74% (8)	54% (14)	60
2	NC	69% (12)	50% (16)	33
3	NC	NC	NC	12
4	NC	NC	NC	0
Total number of patients	27	61	30	—

NC: not calculated where 𝑁<10.